NBP256050PE

Novus Biologicals™ ASNA1 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP256050PE-Each-of-1 In Stock ₹ 31,372.50

NBP256050PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

439

Common Name

ASNA1 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

ARSA, arsA arsenite transporter, ATP-binding, homolog 1 (bacterial), ARSA1, ARSA-I, Arsenical pump-driving ATPase, Arsenite-stimulated ATPase, ATPase ASNA1, EC 3.6, EC 3.6.3.16, GET3, golgi to ER traffic 3 homolog, hARSA-I, hASNA-I, MGC3821, Transmembrane

Label Type

Unlabeled

Quantity

100μL

Research Category

metabolism

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51558. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

GET3

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Source

E.Coli

Related Products

Img

Novus Biologicals™

NBP256409PE

--

Img

Novus Biologicals™

NBP256307PE

--

Img

Novus Biologicals™

NBP256387PE

--

Img

Novus Biologicals™

NBP255993PE

--

Img

Novus Biologicals™

NBP256481PE

--

Img

Novus Biologicals™

NBP255269PE

--

Img

Novus Biologicals™

NBP255813PE

--

Img

Novus Biologicals™

NBP256093PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human ASNA1
  • Source: E.coli Amino Acid Sequence: EPTLSNIIEQRSLKWIFVGGKGGVGKTTCSCSLAVQLSKGRESVLIISTDPAHNISDAFDQKFSKVPTKVKGYDNLFAMEIDPS The ASNA1 Recombinant Protein Antigen is derived from E
  • coli
  • The ASNA1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.